Novartis India [NOVARTIND] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Novartis India Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Novartis India Ltd. wins in 13 metrics, Innova Captab Ltd. wins in 7 metrics, with 0 ties. Novartis India Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Novartis India Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 25.00 31.20 Novartis India Ltd.
Price-to-Book Ratio 3.14 4.05 Novartis India Ltd.
Debt-to-Equity Ratio 0.52 32.95 Novartis India Ltd.
PEG Ratio -1.18 1.33 Innova Captab Ltd.
EV/EBITDA 20.21 20.49 Novartis India Ltd.
Profit Margin (TTM) 27.97% 8.85% Novartis India Ltd.
Operating Margin (TTM) 25.47% 12.88% Novartis India Ltd.
EBITDA Margin (TTM) 25.47% 12.88% Novartis India Ltd.
Return on Equity 12.85% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 10.65% 8.12% Novartis India Ltd.
Free Cash Flow (TTM) $745.70M $-1.09B Novartis India Ltd.
Dividend Yield 2.44% 0.30% Novartis India Ltd.
1-Year Return 49.33% -3.19% Novartis India Ltd.
Price-to-Sales Ratio (TTM) 7.00 2.76 Innova Captab Ltd.
Enterprise Value $18.37B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 5.29 2.90 Innova Captab Ltd.
Gross Profit Margin (TTM) 43.07% 35.19% Novartis India Ltd.
Revenue per Share (TTM) $141 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $39.42 $23.16 Novartis India Ltd.
Beta (Stock Volatility) -0.05 -0.33 Innova Captab Ltd.

Novartis India Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

NOVARTIND
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Novartis India Ltd.-9.47%-10.87%29.78%44.07%63.91%70.30%
Innova Captab Ltd.-0.63%1.28%1.49%32.44%19.52%16.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Novartis India Ltd.49.33%115.71%137.09%117.42%110.10%222.44%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Novartis India Ltd. vs Innova Captab Ltd.

MetricNOVARTINDINNOVACAP
Market Information
Market Cap i₹23.65B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i10,693578,151
90 Day Avg. Volume i14,037217,693
Last Close₹1,326.20₹857.00
52 Week Range₹750.00 - ₹1,588.40₹622.00 - ₹1,020.70
% from 52W High-16.51%-16.04%
All-Time High₹1,588.40 (Jun 01, 2026)₹1,260.00 (Jan 06, 2025)
% from All-Time High-16.51%-31.98%
Growth Metrics
Quarterly Revenue Growth-0.08%0.42%
Quarterly Earnings Growth-0.37%0.23%
Financial Health
Profit Margin (TTM) i0.28%0.09%
Operating Margin (TTM) i0.25%0.13%
Return on Equity (TTM) i0.13%0.13%
Debt to Equity (MRQ) i0.5232.95
Cash & Liquidity
Book Value per Share (MRQ)₹313.93₹178.28
Cash per Share (MRQ)₹250.14₹10.22
Operating Cash Flow (TTM) i₹997.00M₹282.88M
Levered Free Cash Flow (TTM) i₹1.01B₹1.28B
Dividends
Last 12-Month Dividend Yield i2.44%0.30%
Last 12-Month Dividend i₹25.00₹2.00

Valuation & Enterprise Metrics Analysis: Novartis India Ltd. vs Innova Captab Ltd.

MetricNOVARTIND (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i25.0031.20
Forward P/E iN/A21.90
PEG Ratio i-1.181.33
Price to Sales (TTM) i7.002.76
Price to Book (MRQ) i3.144.05
Market Capitalization
Market Capitalization i₹23.65B₹41.43B
Enterprise Value i₹18.37B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i5.292.90
Enterprise to EBITDA i20.2120.49
Risk & Other Metrics
Beta i-0.05-0.33
Book Value per Share (MRQ) i₹313.93₹178.28

Financial Statements Comparison: Novartis India Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNOVARTIND (2025)INNOVACAP (2025)
Revenue/Sales i3.56B12.34B
Cost of Goods Sold i2.06B8.38B
COGS % of Revenue i57.7%67.9%
Gross Profit i1.51B3.96B
Gross Margin i42.3%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i941.70M1.65B
Operating Margin i26.4%13.4%
EBITDA i1.38B2.00B
EBITDA Margin i38.7%16.2%
Pre-Tax Income i1.30B1.71B
Pre-Tax Income % of Revenue i36.6%13.9%
Income Tax i295.20M427.58M
Income Tax % of Revenue i8.3%3.5%
Net Income (Profit) i1.01B1.28B
Profit Margin i28.3%10.4%

Balance Sheet & Liquidity Metrics

MetricNOVARTIND (2025)INNOVACAP (2025)
Cash & Equivalents i520.70M155.19M
Total Current Assets i7.46B7.03B
Total Current Assets % of Revenue i209.3%57.0%
Total Current Liabilities i1.42B3.53B
Total Current Liabilities % of Revenue i39.9%28.6%
Long-Term Debt i32.10M2.45B
Long-Term Debt % of Revenue i0.9%19.8%
Total Shareholders Equity i7.85B9.59B
Retained Earnings i7.69B4.53B
Retained Earnings % of Revenue i215.8%36.7%
Property, Plant & Equipment i35.70M442.93M

Cash Flow Statement Comparison

MetricNOVARTIND (2025)INNOVACAP (2025)
Operating Cash Flow i997.00M282.88M
Operating Cash Flow % of Revenue i28.0%2.3%
Capital Expenditures i3.20M-1.72B
Free Cash Flow i745.70M-1.09B
FCF Margin i20.9%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNOVARTINDINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i24.69M57.22M
Float Shares i6.69M15.91M
% Held by Insiders i72.92%72.19%
% Held by Institutions i0.16%19.22%
% Held by Public i26.92%8.59%

Dividend Analysis & Yield Comparison: Novartis India Ltd. vs Innova Captab Ltd.

MetricNOVARTINDINNOVACAP
Last 12-Month Dividend i₹25.00₹2.00
Last 12-Month Dividend Yield i2.44%0.30%
3-Year Avg Annual Dividend i₹32.50₹0.67
3-Year Avg Dividend Yield i3.57%0.30%
3-Year Total Dividends i₹97.50₹2.00
Ex-Dividend DateJul 23, 2025Jan 30, 2026